Page last updated: 2024-10-31

milrinone and Leukemia

milrinone has been researched along with Leukemia in 1 studies

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research Excerpts

ExcerptRelevanceReference
"We describe the case of a patient with refractory leukemia and end-stage CHF who developed severe dyspnea after discontinuation of milrinone."7.81Intensive symptom control of opioid-refractory dyspnea in congestive heart failure: Role of milrinone in the palliative care unit. ( Bruera, E; Elsayem, A; Montoya, M; Silvestre, J, 2015)
"We describe the case of a patient with refractory leukemia and end-stage CHF who developed severe dyspnea after discontinuation of milrinone."3.81Intensive symptom control of opioid-refractory dyspnea in congestive heart failure: Role of milrinone in the palliative care unit. ( Bruera, E; Elsayem, A; Montoya, M; Silvestre, J, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silvestre, J1
Montoya, M1
Bruera, E1
Elsayem, A1

Other Studies

1 other study available for milrinone and Leukemia

ArticleYear
Intensive symptom control of opioid-refractory dyspnea in congestive heart failure: Role of milrinone in the palliative care unit.
    Palliative & supportive care, 2015, Volume: 13, Issue:6

    Topics: Analgesics, Opioid; Dyspnea; Female; Heart Failure; Humans; Leukemia; Middle Aged; Milrinone; Pallia

2015